BridgeBio Pharma (BBIO) Stock Price
$56.26 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
3 -
Technical
7
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on BridgeBio Pharma, AI stock picks, stock alerts and much more.
BBIO AI Stock Analysis
AI stock analysis for BBIO is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like BridgeBio Pharma (BBIO) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
BridgeBio Pharma (BBIO) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of BridgeBio Pharma (BBIO), currently trading at $56.26, will... Sign up to access price prediction.
About BBIO
-
BridgeBio Pharma, Inc.
-
Symbol
BBIO
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
10.8B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.01 2.2% |
7 |
 |
Inovio Pharmaceuticals INO |
$2.47 5.1% |
2 |
 |
Moderna MRNA |
$27.24 4.7% |
4 |
 |
Anavex Life Sciences AVXL |
$9.36 4.2% |
5 |
 |
Crispr Therapeutics CRSP |
$73.97 7% |
5 |
News
BBIO Alternative Data
Web Traffic
BridgeBio Pharma receives an estimated 25371 monthly visitors to bridgebio.com.
-
Web Traffic
25371
-
Change from Previous Month
10%
-
3 Month Change
15.4%
-
YoY Change
15.4%
Stocktwits Mentions
BridgeBio Pharma has been mentioned an estimated 11 times on Stocktwits over the last 24 hours.
-
Stocktwits Mentions
11
-
Daily Change
15.4%
-
1 Month Change
21.4%
LinkedIn Followers
62,179 are following BridgeBio Pharma on LinkedIn, up by 2% over the last month.
-
LinkedIn Followers
62179
-
Daily Change
0.1%
-
1 Month Change
2%
-
3 Month Change
7.4%
-
YoY Change
7.4%
Job Postings
BridgeBio Pharma currenly has an estimated 41 open job postings, up by 95.2% over the last month.
-
Job Postings
41
-
Daily Change
13.9%
-
1 Month Change
95.2%
-
3 Month Change
46.4%
-
YoY Change
46.4%
LinkedIn Employees
According to LinkedIn, BridgeBio Pharma has 801 employees.
-
LinkedIn Employees
801
-
Daily Change
0.1%
-
1 Month Change
0%
-
3 Month Change
4%
-
YoY Change
4%
Reddit Mentions
BridgeBio Pharma has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at BridgeBio Pharma is 84 out of 100 (very bullish).
-
Business Outlook
84
-
Change from Previous Month
1.2%
-
3 Month Change
1.2%
-
YoY Change
1.2%
News Mentions
BridgeBio Pharma was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
BBIO Financials
BBIO Key Metrics
-
Total Revenue
$116.6M
-
Net Income
-$167.4M
-
Earnings per Share
-$0.88
-
Free cash flow
-$199.2M
-
EBITDA
-$126.2M
-
EBITDA Ratio
-1.08188
-
Total Assets
$881.6M
BBIO 2-year Revenue & Income
BBIO 2-year Free Cash Flow
BBIO Technicals
BBIO SMA
BBIO RSI
FAQ
What's the current price of BridgeBio Pharma (BBIO) Stock?
The price of an BridgeBio Pharma (BBIO) share is $56.26.
What's the market cap of BridgeBio Pharma?
The current market cap of BridgeBio Pharma is 10.8B.
What are some stocks similar to BridgeBio Pharma (BBIO) that investors often compare it to?
BridgeBio Pharma (BBIO) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and Crispr Therapeutics.
What is the forecast for BridgeBio Pharma's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast BridgeBio Pharma's stock price to be around $57.39 in 2026. Starting from the current price of $56.26, this represents a 2% change in price, indicating a neutral outlook for the stock.
How to buy BridgeBio Pharma (BBIO) Stock?
BridgeBio Pharma stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy BridgeBio Pharma shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.